Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1

11 Nov 2022

Abstract excerpt

INTRODUCTION: Paired-related homeobox transcription factor 2 (PRRX2) has been proved involves in the pathogenesis of tumors, but the role of PRRX2 in lung adenocarcinoma (LUAD) is basically not clear. MATERIALS AND METHODS: LUAD datasets were obtained from Gene Expression Omnibus datasets. Functional enrichment analyses were performed based on R language. Several online analysis tools were used for PRRX2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36379103
DOI: 10.1016/j.tranon.2022.101586

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PRRX2 predicts poor survival prognosis, and promotes malignant phenotype of lung adenocarcinoma via transcriptional activates PSMD1PMID 36379103Read ↗

Identifying Proteasome 26S Subunit, ATPase ( <i>PSMC</i> ) Family Genes as the Prognostic Indicators and Therapeutic Targets in Lung AdenocarcinomaSemantic proximity Read ↗

The Expression and Prognostic Role of Peroxiredoxins in Lung CancerSemantic proximity Read ↗

The role and function validation of P2RX4 as a novel cancer biomarker in pan-cancer analysisSemantic proximity Read ↗

Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformaticsSemantic proximity Read ↗

Evaluation of Clinical Value and Potential Mechanism of MTFR2 in Lung Adenocarcinoma via BioinformaticsSemantic proximity Read ↗

MiR-486-5p specifically suppresses SAPCD2 expression, which attenuates the aggressive phenotypes of lung adenocarcinoma cells.Semantic proximity Read ↗

Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformaticsSemantic proximity Read ↗

ADRB2 expression predicts the clinical outcomes and is associated with immune cells infiltration in lung adenocarcinomaSemantic proximity Read ↗

A Novel Mitochondrial-Related Nuclear Gene Signature Predicts Overall Survival of Lung Adenocarcinoma PatientsSemantic proximity Read ↗

ADRB2 Expression Predicts the Clinical Outcomes and is Associated with Immune Cells Infiltration in Lung AdenocarcinomaSemantic proximity Read ↗

Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysisSemantic proximity Read ↗

Advancements and perspectives of RBX2 as a molecular hallmark in cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.